Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection.
Autorzy:
Zykova AA; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Blokhina EA; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Stepanova LA; Smorodintsev Research Institute of Influenza, Russian Ministry of Health, St. Petersburg 197376, Russia. Shuklina MA; Smorodintsev Research Institute of Influenza, Russian Ministry of Health, St. Petersburg 197376, Russia. Ozhereleva OO; Smorodintsev Research Institute of Influenza, Russian Ministry of Health, St. Petersburg 197376, Russia. Tsybalova LM; Smorodintsev Research Institute of Influenza, Russian Ministry of Health, St. Petersburg 197376, Russia. KuprianovVV; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Ravin NV; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia.
Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide.
Autorzy:
Zykova AA; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Blokhina EA; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Kotlyarov RY; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Stepanova LA; Research Institute of Influenza, Russian Ministry of Health, St. Petersburg 23805, Russia. Tsybalova LM; Research Institute of Influenza, Russian Ministry of Health, St. Petersburg 23805, Russia. KuprianovVV; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia. Ravin NV; Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Oct 06; Vol. 12 (10). Date of Electronic Publication: 2020 Oct 06.
Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
Autorzy:
Mardanova ES; Centre 'Bioengineering', Russian Academy of Sciences, Prosp. 60-letya Oktyabrya, bld 7-1, 117312, Moscow, Russia. . Kotlyarov RY; Centre 'Bioengineering', Russian Academy of Sciences, Prosp. 60-letya Oktyabrya, bld 7-1, 117312, Moscow, Russia. . KuprianovVV; Centre 'Bioengineering', Russian Academy of Sciences, Prosp. 60-letya Oktyabrya, bld 7-1, 117312, Moscow, Russia. . Stepanova LA; Research Institute of Influenza, Russian Federation Ministry of Health, 15/17 Prof. Popova str., 197376, St. Petersburg, Russia. . Tsybalova LM; Research Institute of Influenza, Russian Federation Ministry of Health, 15/17 Prof. Popova str., 197376, St. Petersburg, Russia. . Lomonosoff GP; Department of Biological Chemistry, John Innes Centre, Norwich Research Park, NR4 7UH, Norwich, UK. . Ravin NV; Centre 'Bioengineering', Russian Academy of Sciences, Prosp. 60-letya Oktyabrya, bld 7-1, 117312, Moscow, Russia. .
Pokaż więcej
Źródło:
BMC biotechnology [BMC Biotechnol] 2015 May 29; Vol. 15, pp. 42. Date of Electronic Publication: 2015 May 29.
Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Autorzy:
Stepanova LA; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. Kotlyarov RY; Centre 'Bioengineering', Russian Academy of Sciences, Moscow, Russia. Kovaleva AA; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. Potapchuk MV; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. Korotkov AV; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. Sergeeva MV; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. Kasianenko MA; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. KuprianovVV; Centre 'Bioengineering', Russian Academy of Sciences, Moscow, Russia. Ravin NV; Centre 'Bioengineering', Russian Academy of Sciences, Moscow, Russia; GenNanotech Ltd, St. Petersburg, Russia. Tsybalova LM; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia. Skryabin KG; Centre 'Bioengineering', Russian Academy of Sciences, Moscow, Russia. Kiselev OI; Department of Influenza Vaccines, Research Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Mar 23; Vol. 10 (3), pp. e0119520. Date of Electronic Publication: 2015 Mar 23 (Print Publication: 2015).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies